Anteris Aus Operations amends supply agreement with Harvey Industries
The amendment extends the companies' existing supply and quality pact through year-end 2026 or until a new agreement replaces it.
SEC filing
Latest
4 stories
Wednesday, September 23
Thursday, September 17
Anteris Technologies grants contingent options and PSUs to executives, options to McDonnell
The board approved equity awards for CEO Wayne Paterson, David St Denis and Matthew McDonnell on September 12, 2026, with most grants pending stockholder approval.
SEC filing
Tuesday, September 8
Anteris names Brent Moen as new CFO, shifts McDonnell to Australia role
Anteris Technologies Global Corp said Moen will take over as Chief Financial Officer on September 11, 2026, while Matthew McDonnell moves into a new Head of Australia position.
SEC filing
Tuesday, August 11
Anteris reports Q2 2026 progress on PARADIGM Trial, adds two board members
The company secured Medicare reimbursement for its pivotal heart valve trial and began enrolling U.S. patients, while reporting $20.8 million in quarterly operating cash outflows.
SEC filing